Date Filed | Type | Description |
10/04/2023 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
08/10/2023 |
8-K
| Quarterly results |
07/06/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
06/28/2023 |
8-K
| Quarterly results |
04/25/2023 |
8-K
| Quarterly results |
02/13/2023 |
8-K
| Quarterly results |
11/14/2022 |
8-K
| Quarterly results |
10/27/2022 |
8-K
| Quarterly results |
09/29/2022 |
8-K
| Quarterly results |
09/29/2022 |
8-K
| Quarterly results |
09/19/2022 |
8-K
| Quarterly results |
08/09/2022 |
8-K
| Quarterly results |
06/28/2022 |
8-K
| Quarterly results |
03/28/2022 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
03/24/2022 |
8-K
| Entry into a Material Definitive Agreement, Financial Statements and Exhibits Interactive Data |
02/14/2022 |
8-K
| Quarterly results |
11/09/2021 |
8-K
| Quarterly results |
11/01/2021 |
8-K
| Entry into a Material Definitive Agreement Interactive Data |
09/16/2021 |
8-K
| Quarterly results |
08/09/2021 |
8-K
| Quarterly results |
07/01/2021 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
06/24/2021 |
8-K
| Quarterly results |
06/11/2021 |
8-K
| Quarterly results |
03/22/2021 |
8-K
| Quarterly results |
02/10/2021 |
8-K
| Quarterly results |
01/11/2021 |
8-K
| Quarterly results |
12/10/2020 |
8-K
| Entry into a Material Definitive Agreement |
11/03/2020 |
8-K
| Changes in Registrant's Certifying Accountant, Departure of Directors or Certain Officers; Election of Directors; Appointment... |
10/28/2020 |
8-K
| Quarterly results
Docs:
|
"Aethlon Medical Announces Second Quarter Financial Results and Provides Corporate Update SAN DIEGO, CA, October 28, 2020 -- Aethlon Medical, Inc. , a medical device technology company focused on developing products to diagnose and treat life and organ threatening diseases, today reported financial results for its second quarter ended September 30, 2020 and provided an update on recent developments. Company Updates Aethlon Medical, Inc. is continuing the development of its proprietary Hemopurifier®, which is a first in class therapeutic device designed for the single use depletion of cancer-promoting exosomes and circulating viruses. The Hemopurifier has previously been designated a Breakthrough Device by the FDA for the treatment of glycosylated viruses, including Ebola and other hemorrhag..." |
|
09/15/2020 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
08/11/2020 |
8-K
| Quarterly results |
06/25/2020 |
8-K
| Quarterly results |
03/23/2020 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
02/21/2020 |
8-K
| Quarterly results |
|